What does curie.bio invest in?
curie.bio invests most often at Series A (100% of the rounds on record), in sectors such as Gene Therapy, Therapeutics and Medicine.

United States · Investor
Last cheque observed Oct 2026; 2 cheques on record.
AcceleratorDeploying nowLast fund $377M, Jun 2024
Follow curie.bio and see its new cheques in your feed. Start following
2 cheques in the last 12 months
Mostly Series A: 100% of its rounds
Every round we can evidence, newest first2 appearances
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
From the firm's own filings with the SEC, which it must file accurately by law
curie.bio invests most often at Series A (100% of the rounds on record), in sectors such as Gene Therapy, Therapeutics and Medicine.
2 investments on record, 2 of them in the last 12 months. The most recent was in Oct 2026.
Its most recent investments on record: Bolt Biotherapeutics (Undisclosed round, Oct 2026) and R1 Therapeutics (Series A, Mar 2026).
The median round it joins is $99M. It says it writes cheques of $100K to $5.0M.
Yes: it is actively investing, with 2 investments in the last 12 months.
curie.bio is an accelerator based in Boston, United States.
About $999M, as gross assets of its private funds (Oct 2026).
Its latest fund filing with the SEC was in Jun 2024, reporting $377M raised.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it